Sign in Request access
Sign inRequest access
Company profileLarge company (from the award notice)

Libra-Pharm GmbH

Legal form
GmbH
Seat
Aachen, Germany

Based on the notices and sources Inteliwert covers; not a complete record. Last checked 5 October 2026.

Identifiers

Not found in the indexed notices.

Track record in public tenders

Awards in the covered notices over the last 36 months, per CPV division.

Awards per CPV division, last 36 monthsAwards to Libra-Pharm GmbH in the covered notices per CPV division over the last 36 months. 33 Medical equipments, pharmaceuticals and personal care products: 2 awards.33 Medical equipments, pharmaceuticals and personal care products: 2 awards33 Medical equipments, pharmaceuticals and…2 awards
Based on the notices and sources Inteliwert covers; not a complete record.
Awards per CPV division, last 36 months. Based on the notices and sources Inteliwert covers; not a complete record.
CPV divisionAwardsAward value (excl. VAT)BuyersRepeat buyersFirst awardLast award
33 Medical equipments, pharmaceuticals and personal care products2—115 October 20265 October 2026

Awards

Certifications and prequalification

No certification or prequalification found in the covered sources.

A certification missing here is unknown, not absent.

Website and LinkedIn

Website
http://www.grunenthal.de/declared in a notice

Open tenders that might fit

Possible match based on public information

Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.

Is this your company?

Send corrections, or ask us to remove the profile, to hello@inteliwert.com. You can also ask that the company never be tagged on LinkedIn.

About this profile

Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.

Based on the notices and sources Inteliwert covers; not a complete record.

Last checked 5 October 2026.

Markdown version